Pay in 4 interest-free payments of $5.05 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
ATLANTA A once-daily oral quadruple receptor agonist induced up to 13.8% weight loss at 13 weeks among adults with overweight or obesity, according to a speaker at ObesityWeek
Available Options Hims currently lists other weight management products, though it is important to distinguish between them: Compounded Semaglutide Injections: These injectables remain part of the service offering but, like all compounded drugs, are not FDA-approved and operate under the same heightened regulatory scrutiny as other compounded GLP-1s
Semaglutide products include Ozempic, Rybelsus, Wegovy, and Wegovy HD, while tirzepatide products include Mounjaro and Zepbound
Wan S, Coleman FH, and Travagli RA
These programs vary widely: some focus on providing members with tools and coaching to succeed on their weight loss journey, regardless of medication use
US$ 28.03
US$ 20.26
US$ 28.30
US$ 21.94
US$ 24.29
US$ 25.16
US$ 29.20
US$ 20.21
US$ 24.05
